Assessment of response to PRRT including anatomical and molecular imaging as well as novel biomarkers
- Author(s)
- Kong, G; Noe, G; Chiang, C; Herrmann, K; Hope, TA; Michael, M;
- Journal Title
- Journal of Neuroendocrinology
- Publication Type
- Online publication before print
- Abstract
- Peptide receptor radionuclide therapy (PRRT) is an effective treatment for both oncological and hormone control and is a widely accepted standard of care treatment for patients with neuroendocrine neoplasms (NEN). Its use is anticipated to increase significantly, and this demands accurate tools and paradigms to assess treatment response post PRRT. This article outlines the current role and future developments of anatomical, molecular imaging and biomarkers for response assessment to PRRT, highlighting the challenges and provides perspectives for the need to focus on a multimodality, multidisciplinary and individualised approach for patients with this complex heterogeneous disease.
- Keywords
- Prrt; biomarkers; molecular imaging; radiology; response
- Department(s)
- Cancer Imaging; Internal Medicine; Medical Oncology
- Publisher's Version
- https://doi.org/10.1111/jne.13461
- Open Access at Publisher's Site
https://doi.org/10.1111/jne.13461- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-12-17 03:06:43
Last Modified: 2024-12-17 03:14:35